BioCryst Pharmaceuticals, Inc. (BCRX)
9.67
+0.12
(+1.26%)
USD |
NASDAQ |
Aug 24, 16:00
9.77
+0.10
(+1.03%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Liabilities (Quarterly) : 1.012B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.012B |
| March 31, 2026 | 1.019B |
| December 31, 2025 | 633.31M |
| September 30, 2025 | 834.31M |
| June 30, 2025 | 878.78M |
| March 31, 2025 | 931.97M |
| December 31, 2024 | 966.35M |
| September 30, 2024 | 959.82M |
| June 30, 2024 | 948.02M |
| March 31, 2024 | 944.06M |
| December 31, 2023 | 972.49M |
| September 30, 2023 | 933.91M |
| June 30, 2023 | 918.60M |
| March 31, 2023 | 838.02M |
| December 31, 2022 | 844.60M |
| September 30, 2022 | 801.25M |
| June 30, 2022 | 723.77M |
| March 31, 2022 | 691.94M |
| December 31, 2021 | 695.14M |
| September 30, 2021 | 412.81M |
| June 30, 2021 | 383.36M |
| March 31, 2021 | 359.42M |
| December 31, 2020 | 353.98M |
| September 30, 2020 | 142.59M |
| June 30, 2020 | 138.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 132.94M |
| December 31, 2019 | 137.03M |
| September 30, 2019 | 131.75M |
| June 30, 2019 | 125.54M |
| March 31, 2019 | 119.83M |
| December 31, 2018 | 97.61M |
| September 30, 2018 | 95.44M |
| June 30, 2018 | 90.46M |
| March 31, 2018 | 93.32M |
| December 31, 2017 | 94.49M |
| September 30, 2017 | 90.86M |
| June 30, 2017 | 89.43M |
| March 31, 2017 | 90.98M |
| December 31, 2016 | 88.27M |
| September 30, 2016 | 87.51M |
| June 30, 2016 | 68.83M |
| March 31, 2016 | 75.08M |
| December 31, 2015 | 76.83M |
| September 30, 2015 | 74.91M |
| June 30, 2015 | 74.09M |
| March 31, 2015 | 65.50M |
| December 31, 2014 | 61.24M |
| September 30, 2014 | 53.67M |
| June 30, 2014 | 51.89M |
| March 31, 2014 | 49.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.95B |
| Vertex Pharmaceuticals, Inc. | 7.175B |
| Agenus, Inc. | 378.54M |
| Anika Therapeutics, Inc. | 46.19M |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 557.85M |
| Shareholders Equity (Quarterly) | -454.29M |
| Debt to Equity Ratio | -1.842 |
| Current Ratio | 2.321 |
| Net Debt Paydown Yield | -0.06% |